| Title | A phase I/II study to evaluate the safety, tolerability, pharmacokinetics and initial efficacy of recombinant humanized anti-BTLA monoclonal antibody (JS004) injection combined with toripalimab in patients with advanced lung cancer |
|---|---|
| Description | Abstract publication for ASCO 2023 |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA014978 |
| Release Date | 2025-02-15 |
| Submitter | nan zhao (1165095416@qq.com) |
| Organization | Jilin Cancer Hospital |
| Submission Date | 2023-02-15 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002998-01 | PD-L1 & HVEM data JS004-006-I/II-LC | 43 | Biomarker Data | 24.7 KB | zip | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|